# Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia

> **NCT01852331** · PHASE2 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 103 (actual)

## Conditions studied

- Schizophrenia
- Schizophrenic Disorder
- Hyperprolactinemia
- Hyperprolactinaemia

## Interventions

- **DRUG:** PGD granules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01852331
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-04
- **Final completion:** 2014-11
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2015-05-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01852331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01852331, "Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01852331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*